- Clinical trial uses immunotherapy to treat mesothelioma. Baylor College of Medicine. Retrieved from: https://www.bcm.edu/news/cancer/clinical-trial-immunotherapy-mesothelioma. Accessed: 08/13/19.
- MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma. U.S. National Library of Medicine. Retrieved from: https://clinicaltrials.gov/ct2/show/study/NCT04013334. Accessed: 08/12/19.
- Upcoming Phase 2 Trial Will Test Opdivo-MTG201 Combo for Malignant Pleural Mesothelioma. Immuno-Oncology News. Retrieved from: https://immuno-oncologynews.com/2019/08/09/upcoming-phase-2-trial-will-test-opdivo-mtg201-combo-refractory-malignant-pleural-mesothelioma/. Accessed: 08/12/19.
- Immune checkpoint inhibitors to treat cancer. American Cancer Society. Retrieved from: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/immune-checkpoint-inhibitors.html. Accessed: 07/19/19.
- How Does OPDIVO® Work With My Immune System?. Opdivo. Retrieved from: https://www.opdivo.com/about-opdivo/how-opdivo-works.
Sources & Author